Editorial. A neurosurgery resident’s response to COVID-19: anything but routine

por Choi, Bryan D.
Publicado 2020

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas

por Richardson, Leland G., Choi, Bryan D., Curry, William T.
Publicado 2019

A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system

por Choi, Bryan D., Pastan, Ira, Bigner, Darell D., Sampson, John H.
Publicado 2013

Surgical advances in the management of brain metastases

por Ng, Patrick R, Choi, Bryan D, Aghi, Manish K, Nahed, Brian V
Publicado 2021

Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma

por Rhee, John Y., Ghannam, Jack Y., Choi, Bryan D., Gerstner, Elizabeth R.
Publicado 2023

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody

por Choi, Bryan D, Gedeon, Patrick C, Sanchez-Perez, Luis, Bigner, Darell D, Sampson, John H
Publicado 2013

Enzyme Redesign Guided by Cancer-Derived IDH1 Mutations

por Reitman, Zachary J., Choi, Bryan D., Spasojevic, Ivan, Bigner, Darell D., Sampson, John H., Yan, Hai
Publicado 2012

Immunotherapy for malignant glioma

por Suryadevara, Carter M., Verla, Terence, Sanchez-Perez, Luis, Reap, Elizabeth A., Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Publicado 2015

Imaging of Convection Enhanced Delivery of Toxins in Humans

por Mehta, Ankit I., Choi, Bryan D., Raghavan, Raghu, Brady, Martin, Friedman, Allan H., Bigner, Darell D., Pastan, Ira, Sampson, John H.
Publicado 2011

The Role of Antibody-Based Therapies in Neuro-Oncology

por Ramapriyan, Rishab, Sun, Jing, Curry, Annabel, Richardson, Leland G., Ramesh, Tarun, Gaffey, Matthew A., Gedeon, Patrick C., Gerstner, Elizabeth R., Curry, William T., Choi, Bryan D.
Publicado 2023

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice

por Richardson, Leland G., Nieman, Linda T., Stemmer-Rachamimov, Anat O., Zheng, Xijin S., Stafford, Khalifa, Nagashima, Hiroaki, Miller, Julie J., Kiyokawa, Juri, Ting, David T., Wakimoto, Hiroaki, Cahill, Daniel P., Choi, Bryan D., Curry, William T.
Publicado 2020

Myeloablative Temozolomide Enhances CD8(+) T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice

por Sanchez-Perez, Luis A., Choi, Bryan D., Archer, Gary E., Cui, Xiuyu, Flores, Catherine, Johnson, Laura A., Schmittling, Robert J., Snyder, David, Herndon, James E., Bigner, Darell D., Mitchell, Duane A., Sampson, John H.
Publicado 2013

EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma

por Miao, Hongsheng, Choi, Bryan D., Suryadevara, Carter M., Sanchez-Perez, Luis, Yang, Shicheng, De Leon, Gabriel, Sayour, Elias J., McLendon, Roger, Herndon, James E., Healy, Patrick, Archer, Gary E., Bigner, Darell D., Johnson, Laura A., Sampson, John H.
Publicado 2014

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

por Choi, Bryan D., Yu, Xiaoling, Castano, Ana P., Darr, Henia, Henderson, Daniel B., Bouffard, Amanda A., Larson, Rebecca C., Scarfò, Irene, Bailey, Stefanie R., Gerhard, Genevieve M., Frigault, Matthew J., Leick, Mark B., Schmidts, Andrea, Sagert, Jason G., Curry, William T., Carter, Bob S., Maus, Marcela V.
Publicado 2019

A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint p...

por Bernstock, Joshua D., Vicario, Nunzio, Rong, Li, Valdes, Pablo A., Choi, Bryan D., Chen, Jason A., DiToro, Daniel, Osorio, Diana S., Kachurak, Kara, Gessler, Florian, Johnston, James M., Atkinson, T. Prescott, Whitley, Richard J., Bag, Asim K., Gillespie, G. Yancey, Markert, James M., Maric, Dragan, Friedman, Gregory K.
Publicado 2019

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma

por Suryadevara, Carter M., Desai, Rupen, Abel, Melissa L., Riccione, Katherine A., Batich, Kristen A., Shen, Steven H., Chongsathidkiet, Pakawat, Gedeon, Patrick C., Elsamadicy, Aladine A., Snyder, David J., Herndon, James E., Healy, Patrick, Archer, Gary E., Choi, Bryan D., Fecci, Peter E., Sampson, John H., Sanchez-Perez, Luis
Publicado 2018

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources

por Schmidts, Andrea, Marsh, Leah C, Srivastava, Ambike A, Bouffard, Amanda A, Boroughs, Angela C, Scarfò, Irene, Larson, Rebecca C, Bedoya, Felipe, Choi, Bryan D, Frigault, Matthew J, Bailey, Stefanie R, Leick, Mark B, Vatsa, Sonika, Kann, Michael C, Prew, Michelle S, Kleinstiver, Benjamin P, Joung, J Keith, Maus, Marcela V
Publicado 2020

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

por Schmidts, Andrea, Srivastava, Ambike A, Ramapriyan, Rishab, Bailey, Stefanie R, Bouffard, Amanda A, Cahill, Daniel P, Carter, Bob S, Curry, William T, Dunn, Gavin P, Frigault, Matthew J, Gerstner, Elizabeth R, Ghannam, Jack Y, Kann, Michael C, Larson, Rebecca C, Leick, Mark B, Nahed, Brian V, Richardson, Leland G, Scarfò, Irene, Sun, Jing, Wakimoto, Hiroaki, Maus, Marcela V, Choi, Bryan D
Publicado 2022